The latest MoneyTree report shows a dip in first-quarter venture fundingMONEYTREE – More venture capitalists may be kicking the tires these days, but theyÂre not yet big spenders. In the first quarter this year, 14 New Jersey companies pulled in $105.6 million in venture capital, compared with 17 companies that attracted $120.5 million in the fourth quarter of 2005. In last yearÂs first quarter, 18 New Jersey companies received $135.6 million in venture funds.
Compiling the figures was the PricewaterhouseCoopers quarterly MoneyTree survey.
EPAM Systems, a later-stage company that provides software engineering outsourcing services, came away with $25 million, the largest single investment in the first quarter. Transave, an expansion-stage biotechnology company that develops inhalable formulations of drugs for lung disease, took the No. 2 spot with $17.8 million.
Six later-stage companies picked up a total of $65.3 million in the first quarter, or 62% of the overall investment. Three expansion-stage firms garnered $20.2 million, or some 19% of the total, while four early-stage companies received $19.8 million for about another 19%. Just one investment went to a startup, which got $300,000.
Brendan Dougher, managing partner of the Florham Park office of the PricewaterhouseCoopers accounting firm, notes that biotech companies were the leading recipients of first-quarter investments, with three companies taking in a total of $28.1 million. ÂSince New Jersey is home to the pharmaceutical industry, I would expect to see a continued trend of investments in biotech, says Dougher.
On a nationwide basis, venture capitalists invested $5.6 billion in the first quarter, up 12% from the same period a year ago. ÂWe are truly at our healthiest and most sound investment point since the mid-1990s, says Mark Heesen, president of the National Venture Capital Association in Arlington, Va. ÂThat said, we will need to see-improvements in the IPO markets and better evidence of early-stage investing momentum in future quarters if we expect to sustain this reasonable pace.Â
E-mail to mdaks@njbiz.com
ARCHIVE SYSTEMS
Investment: $900,000
25 Commerce Road
Fairfield 07004
Ph: (800) 899-3975
URL: www.archivesystems.com
This was the second round of financing for the expansion-stage document management company.
EPAM SYSTEMS
Investment: $25 million
Princeton Pike Corporate Center
989 Lenox Dr., Suite 305
Lawrenceville 08648
Ph: (609) 844-0400
Fax: (609) 844-0415
url: www.epam.com
The software development and maintenance company closed on its first round of financing provided by private equity firm Siguler Guff & Company, which has offices in Boston and New York City.
HAPTOGUARD
Investment: $300,000
2050 Center Avenue, Suite 200
Fort Lee 07024
Ph: (201) 947-1270
URL: www.biospace.com
The developer of therapeutics for inflammatory diseases agreed last month to be acquired by Parsippany-based Alteon for $8.8 million in stock. Alteon is developing small molecule drugs to treat and prevent inflammatory aspects of diabetes and cardiovascular disease.
HYCRETE TECHNOLOGIES
Investment: $1 million
250 Newark Avenue, Suite 3
Jersey City 07302
Ph: (201) 386-8110
Fax: (201) 386-8115
URL: www.hycrete.com
The early-stage manufacturer of corrosion-resistant and waterproofing products for use with concrete has completed two rounds of financing. Investors include the NJTC Venture Fund.
MAGNOLIA BROADBAND
Investment: $14 million
550 Hills Drive
Bedminster 07921
Ph: (908) 234-0885
Fax: (908) 234-2552
URL: www.magnolia-broadband.com
This later-stage company develops semiconductors and antenna technology for the wireless industry and recently completed its seventh round of financing. New investors include Quantum Technology Partners and WS Investments. Existing ones include Intel Capital, Draper Fisher Jurvetson Gotham, ECentury Capital, SCP Private Equity Partners, Selway Partners, Silverstar Holdings, and Uniquest.
MFORMATION TECHNOLOGIES
Investment: $15.3 million
343 Thornall Street
Edison 08837
Ph: (732) 692-6200
Fax: (732) 549-7542
URL: www.mformation.com
This is the fifth round of financing for this later-stage company that provides software to manage wireless devices. Alex Brown Venture Partners, Battery Ventures, Carmel Ventures, Intel Capital and North Bridge Venture Partners participated in the funding.
NOBLE DEVICE TECHNOLOGIES
Investment: $8 million
211 Warren Street
Newark 07103
Ph: (781) 224-9740
The early-stage developer of visible and infrared image sensors raised $8 million in its first round of financing. Funding came from Matrix Partners and North Bridge Venture Partners. Noble plans to relocate some operations to the Boston area while maintainingfacilities in New Jersey.
ORTHOCON
Investment: $10 million
167 Stone Hill Road
Colts Neck 07722
Ph: (732) 683-9304
Fax (732) 683-9476
URL: www.orthocon.com
An early-stage pharmaceutical and medical device company, Orthocon develops implantable, biodegradable products to be used in orthopedic and other surgical and dental procedures. The firm has closed one round of financing led by BB Biotech Ventures, with participation by Canaan Partners and advisory firm Rockport Venture Partners.
QUINTUM TECHNOLOGIES
Investment: $3.7 million
71 James Way
Eatontown 07724
Ph: (877) 773-2547
Fax: (732) 544-9119
URL: www.quintum.com
This later-stage developer of voice over Internet protocol (VoIP) has completed three rounds of financing.
TACIT NETWORKS
Investment: $6 million
4081 Hadley Road Suite G
South Plainfield 07080
Phone: (908) 757-9950
Fax: (908) 845-0373
URL: www.tacitnetworks.com
This later-stage company provides wide-area file services to distributed computer networks. Brocade Communications Systems was among the investors in the third round of financing.
TERRACYCLE
Investment: $1.5 million
121 New York Avenue
Trenton 08638
Phone: (609) 393-4252
Fax: (609) 393-4259
URL: www.terracycle.org
This expansion-stage company produces plant food from liquified worm waste. New Vantage Group provided the financing.
TF INSTRUMENTS
Investment: $750,000
11 Deer Park Drive, Suite 105A
Monmouth Junction 08852
URL: www.tf-instruments.com
The early-stage company develops ultrasonic resonator technology used to analyze liquid samples for applications in drugs, food processing, cosmetics and medical diagnostics. The company was
established in 2003 as the successor to Resonic Instruments AG, which became insolvent that year.
Transave
Investment: $17.8 million
11 Deer Park Drive
Suite 117
Monmouth Junction 08852
Ph: (732) 438-9434
Fax: (732) 438-9435
URL: www.transaveinc.com
This biotechnology company uses proprietary, sustained-release lipid inhalation technology to develop treatments for lung diseases. The expansion-stage firm has completed five rounds of financing.
VPISYSTEMS
Investment: $1.3 million
943 Holmdel Road
Holmdel 07733
Ph: (732) 332-0233
Fax: (732) 332-0516
URL: www.vpisystems.com
The later-stage developer of software and hardware for communications networks has completed seven rounds of financing. Investors have included Core Capital Partners, Techno Venture Management, Cipio Partners and Siemens Venture Capital.